← Leaderboards
Jinming Gao
Case Western Reserve University
$19,330,906
Attributed
$21,561,632
Total exposure
20
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.1M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,779,412 · 21
By mechanism
R01$11,555,166 · 8
U54$8,455,527 · 3
U01$2,655,516 · 1
R21$2,063,505 · 2
R35$1,968,000 · 1
P41$81,698 · 6
Top collaborators
- Baran D Sumer10 shared
- Gang Huang2 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- John Chae$11,340,256
- Yoram Rudy$11,049,329
- Richard Dwillis Wilson$5,876,592
- David Arthur Cunningham$1,027,614
- Jayme S. Knutson$9,381,227
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsTumorPolymersNanoparticleSignal TransductionMolecularImageResponseMicellesSafetyIn VivoSpecificityHistologyImmuneTechnologyTumor MicroenvironmentDesignBaseTissuesToxic EffectDetectionMagnetic Resonance ImagingPeptidesCells
Grant awards (62)
Precision Engineering of STING-DC Immunity to Overcome Tumor Immune Evasion$984,000
R35 · FY2025 · CA · contact PI
Tumor-activatable Interleukin-2 Superkine Nanoparticle Therapy$399,271
R01 · FY2025 · CA · contact PI
Precision Engineering of STING-DC Immunity to Overcome Tumor Immune Evasion$984,000
R35 · FY2024 · CA · contact PI
Tumor-activatable Interleukin-2 Superkine Nanoparticle Therapy$399,271
R01 · FY2024 · CA · contact PI
STING Activating Synthetic Nanovaccine for HPV-Induced Cancers$368,899
R01 · FY2022 · CA · contact PI
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma$535,530
U01 · FY2021 · CA · contact PI
STING Activating Synthetic Nanovaccine for HPV-Induced Cancers$376,428
R01 · FY2021 · CA · contact PI
pH Transistor Nanoprobes for Detection of Occult Nodal Metastases$366,698
R01 · FY2021 · CA
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma$529,462
U01 · FY2020 · CA · contact PI
STING Activating Synthetic Nanovaccine for HPV-Induced Cancers$376,428
R01 · FY2020 · CA · contact PI
pH Transistor Nanoprobes for Detection of Occult Nodal Metastases$366,698
R01 · FY2020 · CA
Nano-Immuno-Oncology Approaches to Overcome Tumor Immune Evasion$5,217,780
U54 · FY2019 · CA · contact PI
Project 3$1,921,470
U54 · FY2019 · CA · contact PI
Administrative Core$1,316,277
U54 · FY2019 · CA · contact PI
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma$519,464
U01 · FY2019 · CA · contact PI
STING Activating Synthetic Nanovaccine for HPV-Induced Cancers$365,135
R01 · FY2019 · CA · contact PI
Nanoprobe-enabled Delineation of Tumor Margins for Improved Surgical Therapy$359,457
R01 · FY2019 · CA · contact PI
pH Transistor Nanoprobes for Detection of Occult Nodal Metastases$355,696
R01 · FY2019 · CA
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma$535,530
U01 · FY2018 · CA · contact PI
STING Activating Synthetic Nanovaccine for HPV-Induced Cancers$376,428
R01 · FY2018 · CA · contact PI
Nanoprobe-enabled Delineation of Tumor Margins for Improved Surgical Therapy$370,575
R01 · FY2018 · CA · contact PI
pH Transistor Nanoprobes for Detection of Occult Nodal Metastases$366,698
R01 · FY2018 · CA
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma$535,530
U01 · FY2017 · CA · contact PI
Nanoprobe-enabled Delineation of Tumor Margins for Improved Surgical Therapy$370,575
R01 · FY2017 · CA · contact PI
pH Transistor Nanoprobes for Detection of Occult Nodal Metastases$366,698
R01 · FY2017 · CA
Nanoprobe-enabled Delineation of Tumor Margins for Improved Surgical Therapy$370,385
R01 · FY2016 · CA · contact PI
Nanoprobe-enabled Delineation of Tumor Margins for Improved Surgical Therapy$369,431
R01 · FY2015 · CA · contact PI
Ultra-Responsive "ON/OFF" Fluorescent Nanoprobes for Cancer Molecular Imaging$355,818
R01 · FY2014 · EB · contact PI
Ultra-Responsive "ON/OFF" Fluorescent Nanoprobes for Cancer Molecular Imaging$345,915
R01 · FY2013 · EB · contact PI
Ultra-Responsive "ON/OFF" Fluorescent Nanoprobes for Cancer Molecular Imaging$366,725
R01 · FY2012 · EB · contact PI
Ultra-Responsive "ON/OFF" Fluorescent Nanoprobes for Cancer Molecular Imaging$365,669
R01 · FY2011 · EB · contact PI
Ultra-Sensitive MR Probes for Molecular Diagnosis of Lung Cancer$316,002
R01 · FY2011 · CA · contact PI
ULTRA-SENSITIVE MRI PROBES$16,082
P41 · FY2011 · RR · contact PI
Ultra-Sensitive MR Probes for Molecular Diagnosis of Lung Cancer$325,775
R01 · FY2010 · CA · contact PI
Micellar Nanotherapeutics for Targeted Lung Cancer Therapy$268,470
R01 · FY2010 · CA · contact PI
ULTRA-SENSITIVE MRI PROBES$10,458
P41 · FY2010 · RR · contact PI
Ultra-Sensitive MR Probes for Molecular Diagnosis of Lung Cancer$325,775
R01 · FY2009 · CA · contact PI
Micellar Nanotherapeutics for Targeted Lung Cancer Therapy$268,470
R01 · FY2009 · CA · contact PI
MFe2O4-Loaded Polymer Micelles as Ultra-Sensitive MR Molecular Probes (RMI)$112,693
R21 · FY2009 · EB · contact PI
ULTRA-SENSITIVE MRI PROBES$17,838
P41 · FY2009 · RR · contact PI
MFe2O4-Loaded Polymer Micelles as Ultra-Sensitive MR Molecular Probes (RMI)$402,236
R21 · FY2008 · EB · contact PI
Ultra-Sensitive MR Probes for Molecular Diagnosis of Lung Cancer$325,775
R01 · FY2008 · CA · contact PI
Micellar Nanotherapeutics for Targeted Lung Cancer Therapy$268,470
R01 · FY2008 · CA · contact PI
ULTRA-SENSITIVE MRI PROBES$10,458
P41 · FY2008 · RR · contact PI
MFe2O4-Loaded Polymer Micelles as Ultra-Sensitive MR Molecular Probes (RMI)$398,778
R21 · FY2007 · EB · contact PI
Micellar Nanotherapeutics for Targeted Lung Cancer Therapy$268,470
R01 · FY2007 · CA · contact PI
ULTRA-SENSITIVE MRI PROBES$15,122
P41 · FY2007 · RR · contact PI
MFe2O4-Loaded Polymer Micelles as Ultra-Sensitive MR Molecular Probes (RMI)$355,152
R21 · FY2006 · EB · contact PI
MFe2O4-Loaded Polymer Micelles as Ultra-Sensitive MR Molecular Probes (RMI)$58,525
R21 · FY2006 · EB · contact PI
MFE2O4-LOADED POLYMER MICELLES AS ULTRA-SENSITIVE MR MOLECULAR PROBES$11,740
P41 · FY2006 · RR · contact PI
MFe2O4-Loaded Polymer Micelles-Ultra-Sensitive Prob(RMI)$353,621
R21 · FY2005 · EB
Interstitial Drug Delivery to Thermoablated Liver Tumors$221,502
R01 · FY2005 · CA
Interstitial Drug Delivery to Thermoablated Liver Tumors$113,489
R01 · FY2005 · CA
Interstitial Drug Delivery to Thermoablated Liver Tumors$13,976
R01 · FY2005 · CA
Interstitial Drug Delivery to Thermoablated Liver Tumors$306,383
R01 · FY2004 · CA
Interstitial Drug Delivery to Thermoablated Liver Tumors$49,878
R01 · FY2004 · CA
Interstitial Drug Delivery to Thermoablated Liver Tumors$306,383
R01 · FY2003 · CA
In Vivo Measure of Platinum Containing Drugs by CT$191,250
R21 · FY2003 · CA
Interstitial Drug Delivery to Thermoablated Liver Tumors$49,878
R01 · FY2003 · CA
Interstitial Drug Delivery to Thermoablated Liver Tumors$328,633
R01 · FY2002 · CA
In Vivo Measure of Platinum Containing Drugs by CT$191,250
R21 · FY2002 · CA
Interstitial Drug Delivery to Thermoablated Liver Tumors$38,939
R01 · FY2002 · CA